Comments
Loading...

Aquestive Therapeutics Indicazioni sulle azioni

AQSTNASDAQ
Logo offerto da Benzinga Data
Commercio con il pubblico
Commercio con il pubblico
$6.69
0.497.90%
In chiusura: -
$6.70
0.010.15%
After hour: 7:55 PM EDT

Guidance e previsioni

Aquestive Therapeutics fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.

Get Alert
08/11/2025
AQST
Aquestive Therapeutics
FY
2025
$44.00M
$50.00M
$45.14M
05/12/2025
AQST
Aquestive Therapeutics
FY
2025
$44.00M
$50.00M
$49.58M
03/05/2025
AQST
Aquestive Therapeutics
FY
2025
$47.00M
$56.00M
$52.97M
11/04/2024
AQST
Aquestive Therapeutics
FY
2024
$57.00M
$60.00M
$58.01M
09/27/2024
AQST
Aquestive Therapeutics
FY
2024
$57.00M
$60.00M
$58.01M
08/06/2024
AQST
Aquestive Therapeutics
FY
2024
$57.00M
$60.00M
$49.79M
05/07/2024
AQST
Aquestive Therapeutics
FY
2024
$48.00M
$51.00M
$50.21M
03/05/2024
AQST
Aquestive Therapeutics
FY
2024
$48.00M
$51.00M
$48.10M
11/06/2023
AQST
Aquestive Therapeutics
FY
2023
$47.00M
$50.00M
$47.45M
08/07/2023
AQST
Aquestive Therapeutics
FY
2023
$44.00M
$48.00M
$43.37M
05/02/2023
AQST
Aquestive Therapeutics
FY
2023
$42.00M
$46.00M
$39.06M
03/07/2023
AQST
Aquestive Therapeutics
FY
2023
$37.00M
$41.00M
$37.83M
11/01/2022
AQST
Aquestive Therapeutics
FY
2022
$46.00M
$49.00M
$47.01M
08/02/2022
AQST
Aquestive Therapeutics
FY
2022
$46.00M
$49.00M
$46.46M
05/03/2022
AQST
Aquestive Therapeutics
FY
2022
$42.00M
$47.00M
$48.01M
03/08/2022
AQST
Aquestive Therapeutics
FY
2022
$42.00M
$47.00M
$62.68M
11/02/2021
AQST
Aquestive Therapeutics
FY
2021
$47.00M
$49.00M
$48.32M
08/03/2021
AQST
Aquestive Therapeutics
FY
2021
$46.00M
$48.00M
$40.07M
05/04/2021
AQST
Aquestive Therapeutics
FY
2021
$38.00M
$42.00M
$39.13M
03/09/2021
AQST
Aquestive Therapeutics
FY
2021
$38.00M
$42.00M
$41.19M

FAQ

Q

Qual è la guidance più recente per Aquestive Therapeutics (AQST)?

A

Negli ultimi mesi non sono state riportate guidance specifiche sulle vendite o sugli utili di Aquestive Therapeutics.

Sfoglia guidance e previsioni su tutte le azioni.

Le persone guardano anche